OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
March 15, 2021
The agency’s focus appears to be on generic drugs for the upcoming year.
January 02, 2021
Outsourcing increases as the industry balances development and manufacturing of both COVID-19 treatments and non-pandemic-related medicines.
December 03, 2020
USP is preparing for 2021 while also supporting the development of vaccines and treatments for COVID-19.
December 02, 2020
The European Pharmacopoeia is preparing for 2021 while also supporting the industry to develop vaccines and treatments for COVID-19.
October 03, 2020
Industry experts discuss challenges and best practices for scaling up manufacturing under a short deadline.
August 12, 2020
The COVID-19 pandemic has highlighted the challenges and complications of sourcing, tracking, and testing materials for pharmaceuticals. Pharmaceutical Technology spoke with Joe DiMartino, Luminata solution manager at ACD/Labs about the impact COVID-19 is having on the pharmaceutical supply chain and how companies can prepare for these challenges.